# Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome

> **NCT05510596** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 25 (actual)

## Conditions studied

- Lymphoma, B-Cell
- Neurotoxicity

## Interventions

- **OTHER:** Magnetic Resonance Imaging with contrast injection
- **OTHER:** Blood withdrawal
- **OTHER:** Neuropsychological tests

## Key facts

- **NCT ID:** NCT05510596
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-22
- **Primary completion:** 2023-09-13
- **Final completion:** 2023-09-14
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05510596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05510596, "Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05510596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*